|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,631.00 JPY | +0.41% |
|
-1.74% | +16.46% |
| Capitalization | 8,859B 56.42B 48.52B 44.03B 42.22B 77.11B 5,201B 79.89B 517B 207B 2,480B 212B 207B | P/E ratio 2026 * |
50.6x | P/E ratio 2027 * | 30.5x |
|---|---|---|---|---|---|
| Enterprise value | 12,785B 81.42B 70.02B 63.54B 60.94B 111B 7,506B 115B 746B 299B 3,580B 306B 299B | EV / Sales 2026 * |
2.82x | EV / Sales 2027 * | 2.73x |
| Free-Float |
99.61% | Yield 2026 * |
3.57% | Yield 2027 * | 3.63% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.41% | ||
| 1 week | -1.74% | ||
| Current month | -3.23% | ||
| 1 month | +0.70% | ||
| 3 months | +27.69% | ||
| 6 months | +23.11% | ||
| Current year | +16.46% |
| 1 week | 5,562 |  | 5,832 |
| 1 month | 5,465 | | 5,848 |
| Current year | 4,863 | | 5,848 |
| 1 year | 3,916 | | 5,848 |
| 3 years | 3,852 | | 5,848 |
| 5 years | 2,993 | | 5,848 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 59 | 31/03/2015 |
Milano Furuta
DFI | Director of Finance/CFO | - | 31/03/2024 |
Mwana Lugogo
CMP | Compliance Officer | 56 | 31/12/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Weber
BRD | Director/Board Member | 59 | 31/05/2014 |
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
| Director/Board Member | 73 | 31/05/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +7.86% | 24.44% | 29 M€ | |
| +11.68% | 5% | 476 M€ | |
| +11.23% | 3.8% | 2,604 M€ | |
| +5.83% | 3.26% | 96 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.41% | -1.74% | +25.64% | +31.69% | 56.42B | |
| -0.41% | -2.46% | +10.15% | +215.16% | 897B | |
| -0.59% | +0.05% | +48.29% | +59.27% | 591B | |
| +1.00% | +4.09% | +13.68% | +51.35% | 418B | |
| -0.52% | -1.79% | +17.78% | +31.92% | 368B | |
| +0.59% | +0.54% | +25.95% | +41.43% | 313B | |
| -0.16% | -0.41% | +27.58% | +61.05% | 312B | |
| +0.38% | -1.78% | +29.95% | +12.54% | 297B | |
| +0.60% | -1.32% | +21.49% | +61.52% | 204B | |
| +0.26% | +0.75% | +29.18% | +82.83% | 184B | |
| Average | +0.21% | -0.91% | +24.97% | +64.87% | 364.02B | |
| Weighted average by Cap. | +0.13% | -0.83% | +23.83% | +89.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4,529B 28.84B 24.8B 22.51B 21.59B 39.42B 2,659B 40.84B 264B 106B 1,268B 108B 106B | 4,572B 29.12B 25.04B 22.72B 21.79B 39.79B 2,684B 41.23B 267B 107B 1,280B 109B 107B |
| Net income | 172B 1.09B 941M 854M 819M 1.49B 101B 1.55B 10.03B 4.01B 48.09B 4.11B 4.02B | 287B 1.83B 1.57B 1.43B 1.37B 2.5B 169B 2.59B 16.77B 6.71B 80.41B 6.87B 6.72B |
| Net Debt | 3,926B 25B 21.5B 19.51B 18.71B 34.17B 2,305B 35.4B 229B 91.78B 1,099B 93.86B 91.84B | 3,642B 23.19B 19.94B 18.1B 17.36B 31.7B 2,138B 32.84B 213B 85.13B 1,020B 87.07B 85.19B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/03/26 | 5,631.00 ¥ | +0.41% | 4,650,300 |
| 04/03/26 | 5,608.00 ¥ | -2.08% | 5,848,200 |
| 03/03/26 | 5,727.00 ¥ | -1.16% | 4,834,800 |
| 02/03/26 | 5,794.00 ¥ | -0.43% | 4,193,100 |
| 27/02/26 | 5,819.00 ¥ | +1.54% | 6,683,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition